This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Dec 4, 2018Aetna and Ascension Join Five Other Leading Health Care Companies in Blockchain-Driven Effort to Address Health Care Provider Data IssuesPilot Launched in April under Leadership of Humana, MultiPlan, Optum, Quest Diagnostics and UnitedHealthcare
HARTFORD, Conn. & ST. LOUIS (Dec. 3, 2018) – Aetna, a CVS Health business, and Ascension have joined the pilot project applying blockchain technology to improve data quality and reduce...
Dec 4, 2018
Nearly 80 percent of hospital executives surveyed are not at all familiar, or only somewhat familiar, with the Protecting Access to Medicare Act (PAMA) and its impact on hospitals, according to a...
Nov 28, 2018-- Provides outlook for 2019-2022, extending the company's targeted 3-5% revenue compound annual growth rate (CAGR) and updating its adjusted earnings goal to a 4-6% CAGR
At a meeting with analysts and investors at its Investor Day tomorrow, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of...
Nov 28, 2018Quest Diagnostics to Build Flagship Laboratory at Visionary Campus in Clifton, New Jersey to Empower Better Health for Patients in Seven StatesNew lab to be the company's largest in country with more than 1,100 employees, featuring innovative design, automation and expanded capacity
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will build a flagship laboratory in Clifton, N.J. to enhance...
Nov 27, 2018Quest Diagnostics to Acquire the Laboratory Services Business of Boyce and Bynum Pathology Laboratories, Expanding Diagnostic Innovation in the MidwestTransaction aims to provide a broader range of clinical and pathology diagnostic services to patients, hospitals and physicians throughout Missouri and surrounding Midwestern states
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to acquire the assets of the clinical...